Sentence examples for ineffective therapeutics from inspiring English sources

Unfortunately, they have all proven to be ineffective therapeutics.

75 Fibrosis impedes muscle regeneration and may make several of the above therapeutics ineffective.

The results suggest that this non-toxic bioflavonoid may be useful as a chemotherapeutic, particularly in combination with agents that target other components of the tumor cell cycle and in situations where estrogen receptor-specific therapeutics are ineffective.

Because some current breast cancer therapeutics are ineffective in estrogen receptor (ER) negative tumors and since the AhR may be involved in breast cancer proliferation, the effects of galangin on the proliferation of an ER-, AhRhigh line, Hs578T, were studied.

As current antimalarial therapeutics become increasingly ineffective due to parasitic resistance, there exists an urgent need to develop and pursue new therapeutic strategies.

With the emerging insight that T1D represents a heterogeneous disease, the next challenge is to define patient subpopulations that qualify for personalized medicine or that should be enrolled for immune intervention, to maximize clinical benefit and decrease collateral damage by ineffective or even adverse immune therapeutics.

Luis F. Parada (University of Texas Southwestern Medical Center) presented exciting results from a screen for novel drugs to treat glioblastomas and MPNSTs for which current therapeutics are currently ineffective.

It is Inhale Therapeutic Systems, not Inhaled Therapeutics System.

Based on these results, the use of Artemisia tea in cancer therapeutics seems at best unpredictable and at worst ineffective.

However, to date, putative therapeutics that were effective in this animal model have been ineffective in clinical trials in ALS patients, mooting the value of the SOD1 mouse for identifying therapeutics for familial and sporadic ALS.

Development of effective small-molecule RIP inhibitors as therapeutics is challenging because strong electrostatic interactions at the RIPSRL interface make drug-like molecules ineffective in competing with the rRNA for binding to RIPs.